FDA tells Purell to stop claiming it can prevent flu

February 10, 2020

The Food and Drug Administration (FDA) told the maker of Purell to discontinue marketing campaigns that includes claims for avoiding flu and ebola, according to an article on The New York Times website.

The campaigns also claim the product can prevent spread of MRSA and norovirus.

The FDA told Gojo Industries that its claims that Purell could reduce the potential for infection or prevent illnesses violated the Federal Food, Drug and Cosmetic Act. 

The agency said it was reclassifying Purell as an unapproved drug, rather than an over-the-counter product.

Read the article.

See the latest posts on our homepage


Share

Topic Area: Infection Control


Recent Posts
Recent Posts

Florida Assisted-Living Facilities No Longer Required To Test Staff For COVID


Federal guidelines require nursing homes to continue testing

9/23/2020

Pandemic Hastening Closure Of Some Urban Hospitals


COVID has worsened the situation for already weakened hospitals

9/23/2020

Georgia Blocks ‘Granny Cam’ Legislation


Some in the long-term care industry have opposed cameras

9/23/2020

Blog

Tackling the Pandemic with Environmental Monitoring


The benefits of temperature and environmental monitoring are twofold

9/23/2020

Regulations, Codes & Standards Q&A: More On Power Strips


Brad Keyes discusses regulations related to power strips

9/23/2020





Post Comment




FREE
NEWSLETTER

News & Updates • Webcast Alerts • Building Technologies

All fields are required.

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.